[go: up one dir, main page]

ES8106132A1 - Un procedimiento para la preparacion de z-2-acilaminoprope- noatos 3-monosustituidos - Google Patents

Un procedimiento para la preparacion de z-2-acilaminoprope- noatos 3-monosustituidos

Info

Publication number
ES8106132A1
ES8106132A1 ES492553A ES492553A ES8106132A1 ES 8106132 A1 ES8106132 A1 ES 8106132A1 ES 492553 A ES492553 A ES 492553A ES 492553 A ES492553 A ES 492553A ES 8106132 A1 ES8106132 A1 ES 8106132A1
Authority
ES
Spain
Prior art keywords
formula
procedure
preparation
square
noats
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES492553A
Other languages
English (en)
Other versions
ES492553A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26728044&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8106132(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES8106132A1 publication Critical patent/ES8106132A1/es
Publication of ES492553A0 publication Critical patent/ES492553A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE Z-2-ACILAMINOPROPENOATOS 3-MONOSUSTITUIDOS DE FORMULA (I), DONDE R CUADRADO Y R CUBO SON RADICALES HIDROCARBURO DE 3 A 10 DE 1 A 15 ATOMOS DE CARBONO, RESPECTIVAMENTE, Y R ELEVADO A 1 ES HIDROGENO, AMINOALQUILO O DIALQUILAMINOALQUILO. CONSISTE EN HACER REACCIONAR UN CLORURO DE ACIDO DE FORMULA R CUADRADO-COCI CON UN COMPUESTO DE FORMULA (II) EN PRESENCIA DE UNA BASE Y SOMETER EL PRODUCTO FORMADO EN LA ETAPA ANTERIOR A REACCION DE ADICION OXIDATIVA CON METOXIDO SODICO. EL INTERMEDIO RESULTANTE SE TRATA CON ACIDO CLORHIDRICO ANHIDRO. LOS COMPUESTOS OBTENIDOS TIENEN APLICACION COMO INHIBIDORES DE LA DIPEPTIDASA. *FORMULA*
ES492553A 1978-07-24 1980-06-18 Un procedimiento para la preparacion de z-2-acilaminoprope- noatos 3-monosustituidos Granted ES492553A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92721278A 1978-07-24 1978-07-24
US5023379A 1979-06-22 1979-06-22

Publications (2)

Publication Number Publication Date
ES8106132A1 true ES8106132A1 (es) 1981-07-16
ES492553A0 ES492553A0 (es) 1981-07-16

Family

ID=26728044

Family Applications (2)

Application Number Title Priority Date Filing Date
ES482773A Expired ES482773A1 (es) 1978-07-24 1979-07-23 Un procedimiento para la preparacion de z-2-acilaminoprope- noatos-3-monosustituidos.
ES492553A Granted ES492553A0 (es) 1978-07-24 1980-06-18 Un procedimiento para la preparacion de z-2-acilaminoprope- noatos 3-monosustituidos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES482773A Expired ES482773A1 (es) 1978-07-24 1979-07-23 Un procedimiento para la preparacion de z-2-acilaminoprope- noatos-3-monosustituidos.

Country Status (28)

Country Link
EP (1) EP0010573B1 (es)
JP (1) JPS63295540A (es)
KR (1) KR850000425B1 (es)
AT (1) ATE5070T1 (es)
AU (1) AU527772B2 (es)
BG (1) BG60346B2 (es)
CA (1) CA1161058A (es)
CZ (1) CZ280564B6 (es)
DE (1) DE2966328D1 (es)
DK (1) DK157399C (es)
EG (1) EG13961A (es)
ES (2) ES482773A1 (es)
FI (1) FI76069C (es)
GR (1) GR70699B (es)
HK (1) HK5085A (es)
HU (1) HU182531B (es)
IE (1) IE49182B1 (es)
IL (1) IL57797A (es)
MA (1) MA18534A1 (es)
NZ (1) NZ190994A (es)
PH (1) PH16708A (es)
PL (2) PL131618B1 (es)
PT (1) PT69954B (es)
RO (2) RO83292B (es)
SG (1) SG65484G (es)
SU (1) SU1213983A3 (es)
YU (2) YU43455B (es)
ZW (1) ZW13379A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880793A (en) * 1978-07-24 1989-11-14 Merck & Co., Inc. Combination of thienamycin-type antibiotics with dipeptidase inhibitors
PT73640B (en) * 1980-09-17 1983-10-19 Merck & Co Inc Process for preparing chemical compounds selectively inhibit the metabolism of dipeptidase
EP0048025B1 (en) * 1980-09-17 1986-01-15 Merck & Co. Inc. Antibacterial composition of thienamycin type compound and a dipeptidase inhibitor
JPS58170479A (ja) * 1982-03-30 1983-10-07 Sanraku Inc ジペプチダ−ゼ阻害剤
JPS58174345A (ja) * 1982-04-06 1983-10-13 Sumitomo Chem Co Ltd 光学活性２，２−ジメチルシクロプロパン−１−カルボン酸ハライドのラセミ化方法
US4798842A (en) * 1984-07-18 1989-01-17 Schering Corporation Inhibitors of slow reacting substance of anaphylaxis
DE3508564A1 (de) * 1985-03-11 1986-09-11 Degussa Ag, 6000 Frankfurt Verfahren zur herstellung von n-acyl-2, 3-dehydroaminocarbonsaeureestern
US4739113A (en) * 1986-05-30 1988-04-19 Merck & Co., Inc. Bis(cyclopropanecarboxamido)alkadienedioic acids as renal dipeptidase inhibitors
CA2052730A1 (en) 1990-10-11 1992-04-12 Frank P. Dininno 2-(substituted-dibenzofuranyl and dibenzothienyl) carbapenem antibacterial agents
EP0497353B1 (en) * 1991-02-01 2002-05-08 Suntory Limited Use of cilastatin, glutathione or N-acetyl-L-cysteine for the preparation of a medicament for the improvement of gastrointestinal absorption of penem or carbapenem antibiotics
RU2290946C2 (ru) * 2001-01-12 2007-01-10 Фумафарм Аг Амиды фумаровой кислоты
WO2012147941A1 (ja) 2011-04-28 2012-11-01 味の素株式会社 液体洗浄剤組成物
PL442220A1 (pl) 2022-09-07 2024-03-11 Politechnika Wrocławska Sposób i układ do wytwarzania nawozu mikroelementowego

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2449191A (en) * 1945-08-24 1948-09-14 Lilly Co Eli Phenacetylaminomethylcrotonic acid
US2569801A (en) * 1947-02-12 1951-10-02 American Cyanamid Co Preparation of azlactones of phenylacetamino acrylic acids
US2622074A (en) 1949-12-09 1952-12-16 Eastman Kodak Co Salts of alpha-acylamido and alpha-alkoxycarbonamido acrylic acids
BE664781A (es) 1964-06-01
GB1260847A (en) 1968-12-06 1972-01-19 Nat Res Dev Esters of cyclopropane carboxylic acids
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics
DK143712C (da) 1975-11-21 1982-03-22 Merck & Co Inc Fremgangsmaade til fremstilling af de antibiotiske stoffer 890a1 og 890a3
BE848545A (fr) 1975-11-21 1977-05-20 Derives n-methylene substitues de thienamycine,
DK143713C (da) 1975-11-21 1982-03-08 Merck & Co Inc Fremgangsmaade til fremstilling af et antibiotisk stof n-acetyl-thienamycin og salte deraf
DK497476A (da) 1975-11-24 1977-05-25 Merck & Co Inc Fremgangsmade til fremstilling af et antibiotisk stof
US4070477A (en) 1975-12-08 1978-01-24 Ciba-Geigy Corporation 2-Penem compounds
DK487977A (da) 1976-11-17 1978-05-18 Merck & Co Inc Fremgangsmaade til fremstilling af et antiotisk stof
DK487877A (da) 1976-11-17 1978-05-18 Merck & Co Inc Fremgangsmaade til fremstilling af et antibiotisk stof
GB1593524A (en) 1976-11-19 1981-07-15 Merck & Co Inc 1-carba-2-penem-3-carboxylic acids
SE7800978L (sv) 1977-02-11 1978-08-12 Merck & Co Inc Antibiotikum
SE7800979L (sv) 1977-02-11 1978-08-12 Merck & Co Inc Antibiotikum
JPS604719B2 (ja) 1977-03-31 1985-02-06 メルシャン株式会社 β‐ラクタマーゼ阻害活性を有する抗生物質ＰＳ―５の製造方法
US4162323A (en) 1977-04-18 1979-07-24 Merck & Co., Inc. Antibiotic N-acetyl-dehydro-thienamycin
BE867227A (fr) 1977-10-31 1978-11-20 Merck & Co Inc Preparation de l'acide 6-(alpha-hydroxyethyl)-7-oxo-1-azabicyclo (3,2,0) hept-2-ene-carboxylique et derives a activite antibiotique

Also Published As

Publication number Publication date
IE49182B1 (en) 1985-08-21
HK5085A (en) 1985-01-25
BG60346B2 (bg) 1994-09-30
PT69954A (en) 1979-08-01
PL217327A1 (es) 1980-12-01
PL125506B1 (en) 1983-05-31
IL57797A (en) 1986-01-31
EP0010573B1 (en) 1983-10-19
IL57797A0 (en) 1979-11-30
KR850000425B1 (ko) 1985-04-03
RO83292B (ro) 1984-02-28
FI76069C (fi) 1988-09-09
CA1161058A (en) 1984-01-24
ATE5070T1 (de) 1983-11-15
KR830001188A (ko) 1983-04-29
DK157399B (da) 1990-01-02
YU178879A (en) 1983-04-30
GR70699B (es) 1982-12-30
EP0010573A1 (en) 1980-05-14
PT69954B (pt) 1981-06-11
YU43455B (en) 1989-08-31
FI792281A7 (fi) 1980-01-25
DK157399C (da) 1990-05-21
YU43144B (en) 1989-04-30
ES492553A0 (es) 1981-07-16
SU1213983A3 (ru) 1986-02-23
NZ190994A (en) 1981-10-19
RO78106A (ro) 1982-04-12
RO83292A (ro) 1984-02-21
IE791387L (en) 1980-01-24
ES482773A1 (es) 1980-09-01
AU527772B2 (en) 1983-03-24
DE2966328D1 (en) 1983-11-24
JPS63295540A (ja) 1988-12-01
FI76069B (fi) 1988-05-31
YU10183A (en) 1983-04-30
SG65484G (en) 1985-03-29
PL225939A1 (es) 1981-10-02
PL131618B1 (en) 1984-12-31
PH16708A (en) 1984-01-20
MA18534A1 (fr) 1980-04-01
CZ513679A3 (en) 1995-09-13
HU182531B (en) 1984-02-28
AU4893379A (en) 1980-01-31
JPH0440338B2 (es) 1992-07-02
CZ280564B6 (cs) 1996-02-14
EG13961A (en) 1983-03-31
DK309879A (da) 1980-02-28
ZW13379A1 (en) 1981-05-06

Similar Documents

Publication Publication Date Title
ES8106132A1 (es) Un procedimiento para la preparacion de z-2-acilaminoprope- noatos 3-monosustituidos
ES8500241A1 (es) Procedimiento para la preparacion de derivados de imidazol
ES8604582A1 (es) Un metodo para preparar derivados de piperazina
SE7713126L (sv) Schamponeringsmedel med insekticid verkan
ES2087625T3 (es) Derivados de ciclohexano sustituidos, procedimiento para su preparacion y el empleo de los compuestos para el tratamiento de enfermedades.
IL64956A0 (en) Tetrahydronaphthalene and indane derivatives,their manufacture and pharmaceutical compositions containing them
DE3887151D1 (de) Inhibitoren für zellenzuwachs und methoden für krebsbehandlung.
ES494842A0 (es) Un procedimiento para la produccion de una composicion cos- metica del tipo de agua en aceite
ES2060173T3 (es) Derivados de lisolecitina para el tratamiento de enfermedades autoinmunologicas.
IL64472A0 (en) Pharmaceutical compositions containing tricyclic cytosin derivatives,certain new compounds of this class and their production
IL58064A0 (en) Fluorinated polyene compounds their preparation and pharmaceutical compositions containing them
PE26691A1 (es) Procedimiento de preparacion de azabencimidazoles, utiles en el tratamiento de asma, artritis y enfermedades relacionadas
ES8503676A1 (es) Procedimiento de producir derivados de acido oxazolacetico
ES8407476A1 (es) Procedimiento de preparar compuestos piridinicos.
ES8100263A1 (es) Procedimiento para preparar un derivado de acido 1-bencil-1,2,5,6-tetrahidropiridina-3-carboxilico
ATE173615T1 (de) Formulierung und verwendung von carotenoiden in der krebsbehandlung
BR7807615A (pt) Processo para a preparacao de composicoes para adicao ao solo de solubilidade controlada e processo para tratamento de terrenos
ES8105266A1 (es) Un procedimiento para la preparacion de aminoeteres.
ES2078279T3 (es) Procedimiento para la obtencion de disoluciones etericas de halogenuros de arilmetilmagnesio.
ES8600322A1 (es) Un procedimiento para obtener compuestos de 2'-o-acil-, 3'-o-acil-, 2',3'-di-o-acil- y 2',3',5'-tri-o-acil-2-b-d-ribofuranosilselenazol-4-carboxamida
ES2040226T3 (es) Procedimiento para preparar nuevos tetrahidro-benzotiazoles.
FR2443460A1 (fr) Derives mercaptoacyles d'acides 4,5-dihydro-1h-pyrrole-2-carboxyliques et d'acides 1,4,5,6-tetrahydropyridine-2-carboxyliques, utiles comme agents hypotenseurs
AU500172B2 (en) Addition of organic acids to acetylenic compounds
ES8107171A1 (es) Procedimiento para la fabricacion de grupos benzamidina
JPS55157580A (en) Fatty ester of quercetin and white cosmetic comprising it as active ingredient